{"transactions":[{"id":683587,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Performance Stock Units","published_at":"2026-08-18T20:19:02.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the \"Company\") common stock. The performance stock units vest\tupon the Company's common stock achieving certain specified trailing average per share price thresholds."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the \"Company\") common stock. The performance stock units vest\tupon the Company's common stock achieving certain specified trailing average per share price thresholds."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of Celcuity Inc. (the \"Company\") common stock. The performance stock units vest\tupon the Company's common stock achieving certain specified trailing average per share price thresholds."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001716041-26-000004","document":"form4-08182026_080858.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000171604126000004/form4-08182026_080858.xml","form_type":"4"}},{"id":683586,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-08-18T20:19:02.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the total number of restricted stock units vests on the first day of the month following each of the first, second, third and fourth anniversaries of the grant date."}],"balance_after":1271000,"source":{"system":"sec-edgar","filing":"0001716041-26-000004","document":"form4-08182026_080858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000171604126000004/form4-08182026_080858.xml","form_type":"4"}},{"id":749609,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-04T20:52:01.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":20250,"derivative":{"exercise_price":9.89,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001716041-26-000002","document":"form4-06042026_080657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000171604126000002/form4-06042026_080657.xml","form_type":"4"}},{"id":749608,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-06-04T20:52:01.000Z","date":"2026-06-02","kind":"exercise","planned":false,"acquired":true,"shares":1000,"price":9.89,"value":9890.0,"ownership":{"direct":true},"balance_after":1251000,"source":{"system":"sec-edgar","filing":"0001716041-26-000002","document":"form4-06042026_080657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000171604126000002/form4-06042026_080657.xml","form_type":"4"}},{"id":1060327,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-20T20:30:18.000Z","date":"2025-08-18","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25,000 shares vest on 8/18/2026; the remaining 75,000 shares vest 1/36th per month thereafter."}],"balance_after":100000,"derivative":{"exercise_price":51.57,"expiration_date":"2035-08-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-022447","document":"form4-08202025_040804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000141588925022447/form4-08202025_040804.xml","form_type":"4"}},{"id":1263846,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T21:02:58.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":10962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares vest in full on February 21, 2025."}],"balance_after":10962,"derivative":{"exercise_price":12.62,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":10962},"source":{"system":"sec-edgar","filing":"0001415889-25-004378","document":"form4-02182025_090255.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000141588925004378/form4-02182025_090255.xml","form_type":"4"}},{"id":1423295,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-26T21:41:22.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25,000 shares vest on 8/20/25; the remaining 75,000 shares vest 1/36th per month thereafter."}],"balance_after":100000,"derivative":{"exercise_price":17.04,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001062993-24-015671","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000106299324015671/form4a.xml","form_type":"4/A","original_submission_date":"2024-08-22"}},{"id":1425354,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:25:39.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"25,000 shares vest on 8/20/25; the remaining 75,000 shares vest 1/36th per month thereafter."}],"balance_after":100000,"derivative":{"exercise_price":17.04,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001062993-24-015559","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000106299324015559/form4.xml","form_type":"4"}},{"id":1641010,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-15T22:24:05.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":7765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These shares vest in equal amounts on the first day of each month over twelve (12) months, beginning March 1, 2024."}],"balance_after":7765,"derivative":{"exercise_price":15.03,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":7765},"source":{"system":"sec-edgar","filing":"0001062993-24-003326","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000106299324003326/form4.xml","form_type":"4"}},{"id":1794273,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-29T20:42:16.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"31,250 shares vest on 8/25/24; the remaining 93,750 shares vest 1/36th per month thereafter."}],"balance_after":125000,"derivative":{"exercise_price":9.89,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001062993-23-017209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000106299323017209/form4.xml","form_type":"4"}},{"id":1794272,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-08-29T20:42:16.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These shares vest in equal amounts on the last day of each month over seventeen (17) months, beginning August 31, 2023."}],"balance_after":21250,"derivative":{"exercise_price":9.89,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":21250},"source":{"system":"sec-edgar","filing":"0001062993-23-017209","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000106299323017209/form4.xml","form_type":"4"}},{"id":2003621,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-21T21:24:24.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":9156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These shares vest in equal amounts over twelve (12) months, beginning February 16, 2023."}],"balance_after":9156,"derivative":{"exercise_price":11.55,"expiration_date":"2033-02-16","underlying":"Common Stock","underlying_shares":9156},"source":{"system":"sec-edgar","filing":"0001062993-23-004232","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000106299323004232/form4.xml","form_type":"4"}},{"id":2263812,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":38412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022."}],"balance_after":38412,"derivative":{"exercise_price":5.5,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":38412},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263811,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":1877,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter."}],"balance_after":1877,"derivative":{"exercise_price":5.5,"expiration_date":"2031-10-27","underlying":"Common Stock","underlying_shares":1877},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263810,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":1877,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":17.19,"expiration_date":"2031-10-27","underlying":"Common Stock","underlying_shares":1877},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263809,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter."}],"balance_after":20000,"derivative":{"exercise_price":5.5,"expiration_date":"2031-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263808,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":20.04,"expiration_date":"2031-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263807,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":6754,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter."}],"balance_after":6754,"derivative":{"exercise_price":5.5,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":6754},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263806,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":6754,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":27.94,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":6754},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263805,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":2973,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter."}],"balance_after":2973,"derivative":{"exercise_price":5.5,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":2973},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263804,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":2973,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":15.92,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":2973},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263803,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":3215,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter."}],"balance_after":3215,"derivative":{"exercise_price":5.5,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":3215},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263802,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":3215,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":14.84,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":3215},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263801,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":2771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter."}],"balance_after":2771,"derivative":{"exercise_price":5.5,"expiration_date":"2030-12-28","underlying":"Common Stock","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263800,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":2771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":10.35,"expiration_date":"2030-12-28","underlying":"Common Stock","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263799,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter."}],"balance_after":50000,"derivative":{"exercise_price":5.5,"expiration_date":"2029-08-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263798,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":19.72,"expiration_date":"2029-08-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263797,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":1834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"458 shares vest on 10/17/19; the remaining 1,376 shares vest 1/36th per month thereafter."}],"balance_after":1834,"derivative":{"exercise_price":5.5,"expiration_date":"2019-10-17","underlying":"Common Stock","underlying_shares":1834},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263796,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":1834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"458 shares vest on 10/17/19; the remaining 1,376 shares vest 1/36th per month thereafter."}],"balance_after":0,"derivative":{"exercise_price":25.77,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":1834},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263795,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":4110,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":4110,"derivative":{"exercise_price":5.5,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":4110},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2263794,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T00:37:53.000Z","date":"2022-05-17","kind":"disposition_to_issuer","acquired":false,"shares":4110,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":9.5,"expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":4110},"source":{"system":"sec-edgar","filing":"0001437749-22-013127","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000143774922013127/rdgdoc.xml","form_type":"4"}},{"id":2531900,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-29T20:46:06.000Z","date":"2021-10-27","kind":"grant","acquired":true,"shares":1877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter."}],"balance_after":1877,"derivative":{"exercise_price":17.19,"expiration_date":"2031-10-27","underlying":"Common Stock","underlying_shares":1877},"source":{"system":"sec-edgar","filing":"0000914190-21-000382","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419021000382/edgar.xml","form_type":"4"}},{"id":2603752,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-13T20:02:58.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter."}],"balance_after":20000,"derivative":{"exercise_price":20.04,"expiration_date":"2031-08-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000914190-21-000259","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419021000259/edgar.xml","form_type":"4"}},{"id":2749602,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-14T21:47:08.000Z","date":"2021-04-12","kind":"grant","acquired":true,"shares":6754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter."}],"balance_after":6754,"derivative":{"exercise_price":27.94,"expiration_date":"2031-04-12","underlying":"Common Stock","underlying_shares":6754},"source":{"system":"sec-edgar","filing":"0000914190-21-000118","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419021000118/edgar.xml","form_type":"4"}},{"id":2776318,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-22T20:24:55.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":2973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter."}],"balance_after":2973,"derivative":{"exercise_price":15.92,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":2973},"source":{"system":"sec-edgar","filing":"0000914190-21-000087","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419021000087/edgar.xml","form_type":"4"}},{"id":2879254,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T22:12:14.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":3215,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter."}],"balance_after":3215,"derivative":{"exercise_price":14.84,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":3215},"source":{"system":"sec-edgar","filing":"0000914190-21-000030","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419021000030/edgar.xml","form_type":"4"}},{"id":2928890,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-30T22:38:22.000Z","date":"2020-12-28","kind":"grant","acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter."}],"balance_after":2771,"derivative":{"exercise_price":10.35,"expiration_date":"2030-12-28","underlying":"Common Stock","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0000914190-20-000468","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419020000468/edgar.xml","form_type":"4"}},{"id":3057379,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-14T20:20:56.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"5,000 shares vest on 8/12/21; the remaining 15,000 shares vest 1/36th per month thereafter."}],"balance_after":20000,"derivative":{"exercise_price":5.9,"expiration_date":"2030-08-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000914190-20-000297","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419020000297/edgar.xml","form_type":"4"}},{"id":3438845,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-08-14T20:10:00.000Z","date":"2019-08-12","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter."}],"balance_after":50000,"derivative":{"exercise_price":19.72,"expiration_date":"2029-08-12","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000914190-19-000300","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419019000300/edgar.xml","form_type":"4"}},{"id":3786550,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-19T21:20:40.000Z","date":"2018-10-17","kind":"grant","acquired":true,"shares":1834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"458 shares vest on 10/17/19; the remaining 1,376 shares vest 1/36th per month thereafter."}],"balance_after":1834,"derivative":{"exercise_price":25.77,"expiration_date":"2028-10-17","underlying":"Common Stock","underlying_shares":1834},"source":{"system":"sec-edgar","filing":"0001144204-18-054600","document":"tv505120_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000114420418054600/tv505120_4.xml","form_type":"4"}},{"id":4185851,"issuer":{"id":3991,"kind":"organization","name":"Celcuity Inc.","symbol":"CELC"},"owners":[{"id":22254,"kind":"person","name":"Laing Lance G.","position":1,"cik":"0001716041","reported_name":"Laing Lance G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-10-16T20:26:28.000Z","date":"2017-09-19","kind":"grant","acquired":true,"shares":4110,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4110,"derivative":{"exercise_price":9.5,"exercise_date":"2018-09-19","expiration_date":"2027-09-19","underlying":"Common Stock","underlying_shares":4110},"source":{"system":"sec-edgar","filing":"0000914190-17-000312","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1716041/000091419017000312/edgar.xml","form_type":"4"}}]}